FDA — authorised 16 February 2006
- Application: NDA021026
- Marketing authorisation holder: MYLAN
- Local brand name: VUSION
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA authorised Vusion on 16 February 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 February 2006; FDA has authorised it.
MYLAN holds the US marketing authorisation.